Brief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
05/05/2026 07:19
May 5 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST: EGETIS ANNOUNCES GRANT OF PATENT FOR MCT8 DEFICIENCY COMPOSITION IN U.S. Source text: ID:nMFN2yg4fv Further company coverage: EGTX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))